SpectronRx, a radiopharmaceutical contract development and manufacturing organization (rCDMO), has taken the next step in establishing its first European radiolabeling facility.   The company has executed a binding agreement for the completion of its new rCDMO facility on the Belgian Nuclear Research Center (SCK CEN) premises in Mol, Belgium. The build-out of the new facility is scheduled to be completed by November 2024, with an expected operational date of Q1 2025, pending GMP certification ...